S&P 500   4,507.84 (+0.48%)
DOW   35,385.49 (+0.36%)
QQQ   374.32 (+0.45%)
AAPL   148.40 (+1.26%)
MSFT   308.83 (+0.50%)
FB   338.82 (+1.04%)
GOOGL   2,859.39 (+0.13%)
TSLA   867.54 (-0.30%)
AMZN   3,442.48 (-0.12%)
NVDA   221.23 (-0.45%)
BABA   172.36 (+3.32%)
NIO   40.04 (+1.09%)
CGC   13.37 (+1.29%)
GE   104.27 (+0.14%)
AMD   115.23 (-1.03%)
MU   66.97 (-0.43%)
T   25.41 (+0.32%)
F   15.54 (-0.13%)
ACB   6.96 (+0.58%)
DIS   170.91 (-0.13%)
PFE   41.90 (+1.40%)
BA   215.86 (-0.52%)
AMC   43.17 (+0.33%)
S&P 500   4,507.84 (+0.48%)
DOW   35,385.49 (+0.36%)
QQQ   374.32 (+0.45%)
AAPL   148.40 (+1.26%)
MSFT   308.83 (+0.50%)
FB   338.82 (+1.04%)
GOOGL   2,859.39 (+0.13%)
TSLA   867.54 (-0.30%)
AMZN   3,442.48 (-0.12%)
NVDA   221.23 (-0.45%)
BABA   172.36 (+3.32%)
NIO   40.04 (+1.09%)
CGC   13.37 (+1.29%)
GE   104.27 (+0.14%)
AMD   115.23 (-1.03%)
MU   66.97 (-0.43%)
T   25.41 (+0.32%)
F   15.54 (-0.13%)
ACB   6.96 (+0.58%)
DIS   170.91 (-0.13%)
PFE   41.90 (+1.40%)
BA   215.86 (-0.52%)
AMC   43.17 (+0.33%)
S&P 500   4,507.84 (+0.48%)
DOW   35,385.49 (+0.36%)
QQQ   374.32 (+0.45%)
AAPL   148.40 (+1.26%)
MSFT   308.83 (+0.50%)
FB   338.82 (+1.04%)
GOOGL   2,859.39 (+0.13%)
TSLA   867.54 (-0.30%)
AMZN   3,442.48 (-0.12%)
NVDA   221.23 (-0.45%)
BABA   172.36 (+3.32%)
NIO   40.04 (+1.09%)
CGC   13.37 (+1.29%)
GE   104.27 (+0.14%)
AMD   115.23 (-1.03%)
MU   66.97 (-0.43%)
T   25.41 (+0.32%)
F   15.54 (-0.13%)
ACB   6.96 (+0.58%)
DIS   170.91 (-0.13%)
PFE   41.90 (+1.40%)
BA   215.86 (-0.52%)
AMC   43.17 (+0.33%)
S&P 500   4,507.84 (+0.48%)
DOW   35,385.49 (+0.36%)
QQQ   374.32 (+0.45%)
AAPL   148.40 (+1.26%)
MSFT   308.83 (+0.50%)
FB   338.82 (+1.04%)
GOOGL   2,859.39 (+0.13%)
TSLA   867.54 (-0.30%)
AMZN   3,442.48 (-0.12%)
NVDA   221.23 (-0.45%)
BABA   172.36 (+3.32%)
NIO   40.04 (+1.09%)
CGC   13.37 (+1.29%)
GE   104.27 (+0.14%)
AMD   115.23 (-1.03%)
MU   66.97 (-0.43%)
T   25.41 (+0.32%)
F   15.54 (-0.13%)
ACB   6.96 (+0.58%)
DIS   170.91 (-0.13%)
PFE   41.90 (+1.40%)
BA   215.86 (-0.52%)
AMC   43.17 (+0.33%)
NYSE:CLB

Core Laboratories Price Target, Predictions & Analyst Ratings

$29.52
-0.61 (-2.02 %)
(As of 10/19/2021 10:18 AM ET)
Add
Compare
Today's Range
$29.40
$30.00
50-Day Range
$24.50
$31.71
52-Week Range
$13.43
$49.87
Volume1,922 shs
Average Volume504,789 shs
Market Capitalization$1.37 billion
P/E Ratio41.00
Dividend Yield0.13%
Beta3.19

Core Laboratories (NYSE:CLB) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Hold
Based on 7 Analyst Ratings

Analyst Price Target Consensus

$26.79

High PT$36.00
Average PT$26.79
Low PT$17.50
TypeCurrent
10/19/20 to 10/19/21
1 Month Ago
9/19/20 to 9/19/21
3 Months Ago
7/21/20 to 7/21/21
1 Year Ago
10/20/19 to 10/19/20
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
Hold
4 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
12 Hold rating(s)
Sell
3 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$26.79$26.42$26.00$26.96
Price Target Upside-9.26% Downside-11.17% Downside-10.87% Downside3.94% Upside
Get Core Laboratories Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Core Laboratories (NYSE:CLB) vs. Its Competitors

TypeCore LaboratoriesOils/Energy CompaniesS&P 500
Consensus Rating Score
1.57
2.42
2.56
Consensus RatingHoldHoldBuy
Price Target Upside19.07% Upside7.82% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
469
58.85%
Underperform Votes
328
41.15%
Avg. Outperform Votes
271
65.14%
Avg. Underperform Votes
145
34.86%
Avg. Outperform Votes
830
69.46%
Avg. Underperform Votes
365
30.54%

Core Laboratories (NYSE:CLB) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/18/2021Bank of America
DowngradeNeutral ➝ Underperform$36.00 ➝ $32.00+1.46%
10/11/2021Morgan Stanley
Connor Lynagh
Lower Price TargetEqual Weight$37.00 ➝ $34.00+12.25%
8/20/2021Piper Sandler
Lower Price TargetNeutral$20.00 ➝ $17.50-29.18%
6/14/2021Citigroup
DowngradeNeutral ➝ Sell$30.00 ➝ $36.00-24.70%
1/11/2021Wolfe Research
UpgradeUnderperform ➝ Market Perform
12/18/2020JPMorgan Chase & Co.
DowngradeNeutral ➝ Underweight$17.00 ➝ $18.00-30.15%
12/15/2020Smith Barney Citigroup
Boost Price Target$16.00 ➝ $30.00+6.53%
11/11/2020Cowen
Lower Price TargetMarket Perform$26.00 ➝ $20.00+10.38%
9/29/2020ABN Amro
UpgradeSell ➝ Hold
7/24/2020Stifel Nicolaus
Boost Price TargetHold$15.00 ➝ $22.00-8.26%
7/16/2020Scotiabank
Vaibhav Vaishnav
DowngradeSector Outperform ➝ Sector Perform$19.00-11.17%
4/27/2020Royal Bank of Canada
Reiterated RatingBuy
3/17/2020Evercore ISI
James West
DowngradeHold
1/30/2020Johnson Rice
Initiated CoverageBuy
1/14/2020Bernstein Bank
Initiated CoverageMarket Perform$38.80-3.41%
1/13/2020Sanford C. Bernstein
Initiated CoverageMarket Perform$38.00 ➝ $38.80-3.58%
6/26/2019Piper Jaffray Companies
Ian Macpherson
Set Price TargetHold$52.00+4.00%
2/25/2019Tudor Pickering
UpgradeHold ➝ Buy
2/2/2019UBS Group
Sasha Sanwal
Set Price TargetHold$72.00+6.51%
12/19/2018Credit Suisse Group
James Wicklund
DowngradeOutperform ➝ Neutral$105.00 ➝ $75.00+16.75%
11/16/2018Guggenheim
UpgradeNeutral ➝ Buy$120.00+42.52%
(Data available from 10/19/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)












Core Laboratories (NYSE:CLB) Analyst Ratings Frequently Asked Questions

What is Core Laboratories's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for Core Laboratories stock is Hold based on the current 3 sell ratings and 4 hold ratings for CLB. The average twelve-month price target for Core Laboratories is $26.79 with a high price target of $36.00 and a low price target of $17.50. Learn more on CLB's analyst rating history

Do Wall Street analysts like Core Laboratories more than its competitors?

Analysts like Core Laboratories stock less than the stock of other Oils/Energy companies. The consensus rating score for Core Laboratories is 1.57 while the average consensus rating score for oils/energy companies is 2.42. Learn more on how CLB compares to other companies

Do MarketBeat users like Core Laboratories more than its competitors?

MarketBeat users like Core Laboratories stock less than the stock of other Oils/Energy companies. 58.85% of MarketBeat users gave Core Laboratories an outperform vote while oils/energy companies recieve an average of 65.14% outperform votes by MarketBeat users.

Is Core Laboratories being downgraded by Wall Street analysts?

Over the previous 90 days, Core Laboratories's stock had 1 downgrade by analysts.

Does Core Laboratories's stock price have much downside?

According to analysts, Core Laboratories's stock has a predicted downside of -9.47% based on their 12-month price targets.

What analysts cover Core Laboratories?

Core Laboratories has been rated by Bank of America, Morgan Stanley, and Piper Sandler in the past 90 days.

This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.